BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35975918)

  • 1. Controversy Over Liver Transplantation or Resection for Neuroendocrine Liver Metastasis: Tumor Biology Cuts the Deal.
    Eshmuminov D; Studer DJ; Lopez Lopez V; Schneider MA; Lerut J; Lo M; Sher L; Musholt TJ; Lozan O; Bouzakri N; Sposito C; Miceli R; Barat S; Morris D; Oehler H; Schreckenbach T; Husen P; Rosen CB; Gores GJ; Masui T; Cheung TT; Kim-Fuchs C; Perren A; Dutkowski P; Petrowsky H; Thiis-Evensen E; Line PD; Grat M; Partelli S; Falconi M; Tanno L; Robles-Campos R; Mazzaferro V; Clavien PA; Lehmann K
    Ann Surg; 2023 May; 277(5):e1063-e1071. PubMed ID: 35975918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.
    Menahem B; Lubrano J; Duvoux C; Mulliri A; Alves A; Costentin C; Mallat A; Launoy G; Laurent A
    Liver Transpl; 2017 Jun; 23(6):836-844. PubMed ID: 28295992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy.
    Lei JY; Yan LN; Wang WT
    World J Gastroenterol; 2013 Jul; 19(27):4400-8. PubMed ID: 23885153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation.
    Ruzzenente A; Bagante F; Bertuzzo F; Aldrighetti L; Campagnaro T; Ercolani G; Conci S; Giuliante F; Dore A; Ferrero A; Torzilli G; Grazi GL; Ratti F; Cucchetti A; De Rose AM; Russolillo N; Cimino M; Perri P; Guglielmi A; Iacono C
    J Gastrointest Surg; 2019 Jan; 23(1):93-100. PubMed ID: 30242647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation vs liver resection in patients with HBV-related hepatocellular carcinoma beyond Milan criterion: A meta-analysis.
    Li W; Li L; Han J; Wu H
    Clin Transplant; 2018 Mar; 32(3):e13193. PubMed ID: 29315813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation as an alternative for the treatment of neuroendocrine liver metastasis: Appraisal of the current evidence.
    Müller PC; Pfister M; Eshmuminov D; Lehmann K
    Hepatobiliary Pancreat Dis Int; 2024 Apr; 23(2):146-153. PubMed ID: 37634987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of resection versus transplantation for neuroendocrine liver metastases meeting the Milan criteria.
    Maspero M; Rossi RE; Sposito C; Coppa J; Citterio D; Mazzaferro V
    Am J Transplant; 2022 Nov; 22(11):2598-2607. PubMed ID: 35869798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantage of early liver transplantation whenever indicated for hepatocellular carcinoma recurrence after primary liver resection.
    Chan KM; Wu TH; Cheng CH; Lee CF; Wu TJ; Chou HS; Lee WC
    Biomed J; 2019 Oct; 42(5):335-342. PubMed ID: 31783994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
    Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK
    Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.
    Fuks D; Dokmak S; Paradis V; Diouf M; Durand F; Belghiti J
    Hepatology; 2012 Jan; 55(1):132-40. PubMed ID: 21932387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
    Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
    Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma.
    Lee KK; Kim DG; Moon IS; Lee MD; Park JH
    J Surg Oncol; 2010 Jan; 101(1):47-53. PubMed ID: 19798686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation is an alternative treatment of hepatocellular carcinoma beyond the Milan criteria.
    Fan HL; Chen TW; Hsieh CB; Jan HC; His SC; De-Chuan C; Chu CH; Yu JC
    Am J Surg; 2010 Aug; 200(2):252-7. PubMed ID: 20122677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in Child's A cirrhosis: a retrospective analysis of matched pairs following liver transplantation vs. liver resection according to the intention-to-treat principle.
    Foltys D; Zimmermann T; Kaths M; Strempel M; Heise M; Hoppe-Lotichius M; Weiler N; Scheuermann U; Ruckes C; Hansen T; Pitton M; Otto G
    Clin Transplant; 2014 Jan; 28(1):37-46. PubMed ID: 24171713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection vs Transplant Listing for Hepatocellular Carcinoma: An Intention-to-Treat Analysis.
    Meyerovich G; Goykhman Y; Nakache R; Nachmany I; Lahat G; Shibolet O; Menachem Y; Katchman H; Wolf I; Geva R; Klausner JM; Lubezky N
    Transplant Proc; 2019; 51(6):1867-1873. PubMed ID: 31399171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score.
    Lanari J; Hagness M; Sartori A; Rosso E; Gringeri E; Dueland S; Cillo U; Line PD
    Transpl Int; 2021 Sep; 34(9):1722-1732. PubMed ID: 34448271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Imaging Reporting and Data System Category on Magnetic Resonance Imaging Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation Within the Milan Criteria: A Multicenter Study.
    Lee S; Kim KW; Jeong WK; Jeong SY; Hwang JA; Choi JS; Lee SG; Joh JW
    Ann Surg Oncol; 2021 Oct; 28(11):6782-6789. PubMed ID: 33751296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the long-term outcomes of patients with hepatocellular carcinoma within the Milan criteria treated by ablation, resection, or transplantation.
    Zhang NN; Zheng J; Wu Y; Lv JY; Zhang SW; Zhang YM; Jiang WT; Song TQ; Kim V; Tohme S; Liu T; Zhang W; Gu J; Wang ZY; Suo YH; Wang S; Li W; Zhang L; Xie Y; Zhou YH; Liu JY; Qiu YB; Shen ZY; Hao JH; Geller D; Lu W
    Cancer Med; 2023 Feb; 12(3):2312-2324. PubMed ID: 36016484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
    Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C
    Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefit of transplantation for recurrence of hepatocellular carcinoma after liver resection.
    Tuci F; Vitale A; D'Amico F; Gringeri E; Neri D; Zanus G; Bassi D; Polacco M; Boetto R; Lodo E; Germani G; Burra P; Angeli P; Cillo U
    Transplant Proc; 2014 Sep; 46(7):2287-9. PubMed ID: 25242770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.